Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines

about

Harnessing benefit from targeting tumor associated carbohydrate antigens.Breast Cancer Vaccines: New Insights.Virus-like particle display of HER2 induces potent anti-cancer responses.

P2860

Q39032812-C0A71A81-9CF8-4756-B352-E05DAA8FB6F7 Q42683276-AF94FC89-1D74-4662-9101-74E4B1C81F19 Q52699878-7E9AE3DD-383D-41DD-8D83-792432899852

P2860

Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines

Item

http://www.wikidata.org/entity/Q37173925

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Polyclonal immune responses to ...... ies to enhance cancer vaccines

@en

Polyclonal immune responses to ...... es to enhance cancer vaccines.

@nl

type

Item

label

Polyclonal immune responses to ...... ies to enhance cancer vaccines

@en

Polyclonal immune responses to ...... es to enhance cancer vaccines.

@nl

prefLabel

Polyclonal immune responses to ...... ies to enhance cancer vaccines

@en

Polyclonal immune responses to ...... es to enhance cancer vaccines.

@nl

P1476

Polyclonal immune responses to ...... ies to enhance cancer vaccines

@en

P2093

Amy Hobeika

http://www.w3.org/2001/XMLSchema#string

Gayathri Devi

http://www.w3.org/2001/XMLSchema#string

Michael A Morse

http://www.w3.org/2001/XMLSchema#string

Takuya Osada

http://www.w3.org/2001/XMLSchema#string

Timothy M Clay

http://www.w3.org/2001/XMLSchema#string

Zachary C Hartman

http://www.w3.org/2001/XMLSchema#string

P2860

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Cetuximab for the treatment of colorectal cancer.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

The consensus coding sequences of human breast and colorectal cancers

P2888

s12026-010-8186-6

P304

235-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12026-010-8186-6

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Herbert Kim Lyerly

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21136201

http://www.w3.org/2001/XMLSchema#string

P932

3774015

http://www.w3.org/2001/XMLSchema#string

Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines

about

P2860

P2860

Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932